In Nucleic Acids Research this week: chromatin accessibility profiles in P. falciparum during development, transcriptional start sites and regulatory patterns in A. baumannii, and more.
A number of consumer genetic testing companies are adopting best practice guidelines for customer privacy, the Washington Post reports.
Researchers in Japan being a new trial of induced pluripotent stem cells to treat Parkinson's disease, Science reports.
Yale School of Medicine's Michael Murray argues in the Annals of Internal Medicine for making genomic screening routine.
In PNAS this week: Smyd1 regulates mitochondrial metabolism in the heart, evolutionary history of ASICs, and more.
The South China Morning Post reports that DNA testing kit makers are investing in China.
The Wall Street Journal reports that CRISPR researchers are trying to work with communities where the use of gene drives is being considered.
The Post and Courier discusses a South Carolina court's decision in the Williams v Quest case.
In PLOS this week: ties between complex traits and autozygosity, salt tolerance markers in the Chinese rose, and more.
The Canada Border Services Agency is using DNA testing and ancestry testing to deport migrants, Vice reports.
Stat News reports that IBM's Watson supercomputer sometimes gives inappropriate cancer treatment advice.
Early trial results seem promising for Alzheimer's disease treatments, the Los Angeles Times reports.
In Science this week: gene linked to eusociality in ants, and more.
All 19 cities whose air was sampled for a study harbored antibiotic resistance genes, Newsweek reports.
Stat News reports federal regulators have halted Sarepta Therapeutics' Duchenne muscular dystrophy gene therapy trial.
Pharmaceutical company GlaxoSmithKline and direct-to-consumer genetic testing company 23andMe have formed a drug discovery collaboration deal.
In Nature this week: business of genomic testing for pets, and more.
Gene editing is a type of genetic modification, according to a new European Court of Justice ruling.
Wired looks into Moderna Therapeutics' work on personalized cancer vaccines.
A US News & World Report Smarter Investor blog post discusses applying genetic testing to financial planning.
In Cell this week: structural variants affecting regulatory loci in prostate cancer, immune features in the breast cancer microenvironment, and more.
Though prestigious schools get more in funding, less-prestigious schools squeeze more out of the funding they receive, an opinion piece at Bloomberg says.
Jess Wade, a postdoc at Imperial College London, hopes to raise the profiles of women in science by writing their Wikipedia pages, the Guardian reports.
Vox looks into how mitochondrial replacement therapy is treated in the UK and US.
In PNAS this week: single-cell analysis of blood cells from malaria mosquito vector, genes contributing to high yield in rice, and more.
At Nature, a graduate student describes how to explore careers outside academia and what PhD programs can do help that search.
A new analysis of research funding finds that after receiving their first award, female researchers are just about as likely to receive additional awards as male researchers.
The Nature Jobs blog reports that the University of Chicago is no longer requiring graduate school applicants to submit standardized test scores.
At Nature, the University of Alberta's Devang Mehta calls on PIs to engage in conversations about racism.